Previous Next Low-value Care AI has arrived in medical imaging. Now the FDA needs to monitor its impact on patients Abstract: This is the moment of truth for the FDA’s regulation of artificial intelligence in medicine. Publication: STAT Date Published: February 20, 2020 Author(s): Casey Ross View This Resource